Google says Isomorphic Labs researchers use Gemini 4 Argon to cut weeks of patent and paper review down to hours
At @IsomorphicLabs, researchers are using Gemini 4 Argon as a partner to accelerate drug discovery and design research 馃К Argon quickly synthesizes complex PDFs and patents to extract pertinent information, reducing a process that typically takes weeks into just hours.
Context
Drug discovery involves huge amounts of dense reading, and if general AI models can reliably pull data from long patents it could speed up early research.
This is a promotional post from Google about its own model and Alphabet's own drug discovery company, so the time savings are Google's claims. The same case study appeared in Google's Gemini 4 Argon launch post on October 13, so this is a resurfaced example rather than new news.
- Google blog: Gemini 4 Argon is now available for everyone
- Isomorphic Labs: the Drug Design Engine beyond AlphaFold
- ARC Prize: Gemini 4 Argon results
- arcprize on X: Gemini 4 Argon on ARC AGI
- antigravity on X: Argon rolling out to Google AI Pro
- _mohansolo on X: Argon live in Antigravity for paid Pro subscribers
Deep dive
On October 15, Google posted that researchers at Isomorphic Labs are using Gemini 4 Argon as a partner to accelerate drug discovery and design research, and that Argon quickly synthesizes complex PDFs and patents to extract pertinent information, reducing a process that typically takes weeks into hours.
The example comes from Google's Gemini 4 Argon launch post, which uses nearly the same sentence. That post also describes Google scientists working with Argon to design serine esterase enzymes, saying the model assembled data, tuned models and produced five novel designs in hours, and that lab testing confirmed catalytic activity.
In a Google DeepMind video accompanying the launch, Isomorphic researchers say chemistry patents can run to 500 pages with structures far from their experimental results, and one says Argon produced reports on 10 patents in an afternoon, work he put at nearly a month by hand. They say Isomorphic builds specialized models for drug design, while a general model like Gemini handles the reading and summarizing around them.
Isomorphic Labs, an Alphabet company, has separately described its own Drug Design Engine, which it says goes beyond AlphaFold 3.
Also on October 15, ARC Prize posted verified results for Gemini 4 Argon: 97.5% on ARC AGI 3 at $4.8K with a provider adapter harness but 49.8% with its standard harness, 91.3% on ARC AGI 2 and 98.5% on ARC AGI 1. Its results page notes the standard harness runs were incomplete because of API issues. In the evening, Google's Antigravity coding tool said it was rolling Argon out to paid Google AI Pro subscribers with a separate weekly quota.
What to expect next
Watch whether Isomorphic or outside drug companies publish measured results on how accurate Argon's patent extraction is, beyond the researchers' own accounts.
Also watch whether Isomorphic's own drug candidates reach clinical trials, which is the real test of AI driven drug discovery, and whether rival labs pitch similar science workflows. Independent researchers testing Argon on their own patents would offer a fairer view of its accuracy.